메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기
Quratis

We hope to become a company with a social impact that leads the human public health.

Tuberculosis News

The BCG vaccine split"...The 20 fold gap of mortality rate by Corona19 between countries
관리자|2020-04-01 Hit|677

"The BCG vaccine split"...The 20 fold gap of mortality rate by Corona19 between countries

 

Death per million " 0.8 in inoculation countries vs 16.4 in non-adoption countries"...1.9 Koreans
Corona19 mortality rates in non-adopted countries such as Italy, the United States, Belgium and others are high.

 


A study found that vaccinations of infant BCG to prevent tuberculosis helped curb the death toll of the new coronavirus (Korona 19). The researchers speculated that BCG vaccinations could protect against overall respiratory infections.

Researchers at the New York Institute of Technology (NIC) said Thursday that BCG vaccinations have significantly reduced mortality rates. It explained that policy has shown that the number of deaths per 1 million people in countries that vaccinate BCG is much lower than those in countries that do not.


This explains that countries like the United States and Italy, which do not actually carry out BCG vaccinations, are more seriously affected by Corona19. The study was published on MedRxiv, a pre-release site for medical papers from abroad.

BCG is a tuberculosis prevention vaccine that uses non-pathogenic BCG strains to form an immunity to tuberculosis. In particular, it is effective in preventing serious tuberculosis outbreaks, such as tuberculosis in children and meningitis in tuberculosis.

Previous studies have shown that BCG vaccines affect the generation of interlucin-1beta (IL-1β) known to play an important role in anti-viral immunity. This not only helps fight tuberculosis but also other respiratory diseases, according In the West African country of Guinea-Bissau, children were vaccinated against BCG, reducing the incidence of respiratory infections and sepsis, leading to a significant reduction in child mortality.

An analysis based on the March 21 figures showed that Corona19 deaths in 55 countries where BCG vaccinations were carried out averaged 0.78 per million people, with five countries without a universal BCG vaccination policy standing at 16.39. It is about 21 times the difference in figures. The five major BCG non-adopted countries are Italy, the United States, Lebanon, the Netherlands and Belgium.

The researchers also explained that the duration of BCG inoculation and mortality are related. Spain conducted BCG vaccinations for 16 years from 1965 to 1981. Denmark, on the other hand, was implemented for 40 years from 1946 to 1986. The death toll for every 1 million people in the two countries is about 10 times different from 29.5 and 2.3, respectively.

Japan, which has been vaccinating BCG since 1947, has 0.28 deaths per 1 million people, while Brazil, which started vaccinating BCG in the 1920s, has 0.0573 deaths per 1 million people.

Some countries have recorded high confirmed cases and deaths while carrying out BCG vaccinations. The paper analyzed that in the case of Iran, vaccinations only began in 1984, and that previous births did not see immunization effects from vaccines. For China, which started vaccinating BCG in the 1950s, it also speculated that some age groups were more vulnerable to infection due to the cultural revolution (1966-1976) and the dissolution of tuberculosis prevention and treatment institutions.

Meanwhile, Korea began vaccinating infants within four weeks of birth in 1962 under the World Health Organization guidelines Based on 102 deaths as of midnight on Monday, 1.9 out of 1 million Koreans died of coronavirus 19. BCG injections are also called non-injection due to the presence of convex scars.